Prabowo Calls for Equal Hospital Treatment for BPJS Patients

President Prabowo Subianto has instructed Indonesia’s health minister to ensure hospitals treat patients equally, whether they are covered by BPJS Kesehatan or not. The directive came alongside a review of service improvements and the programme’s financial support for 2026.

The government has announced an additional Rp20 trillion for BPJS Kesehatan, on top of the existing budget for premium assistance recipients. The measures put service quality, fairness and financial sustainability at the centre of the administration’s latest discussion on national health insurance.

Equal treatment across hospital wards

At a limited meeting at the Presidential Palace in Jakarta, Prabowo asked Health Minister Budi Gunadi Sadikin to pursue improvements to BPJS services. These include shorter waiting times and better patient care, Sadikin said at a press conference after the meeting.

The instruction on equal treatment addresses a basic test for a public insurance programme: whether coverage status affects the care a patient receives. Prabowo’s direction, as reported by Sadikin, was that hospitals should treat all patients equally, regardless of whether they are covered by BPJS.

The source report does not set out a new enforcement mechanism or describe changes to hospital procedures. For now, the announcement is a policy instruction to the health minister, paired with a broader call to improve the participant experience.

Additional support for the programme

Finance Minister Suahasil Nazara said the Rp20 trillion allocation is additional to the budget already provided for 96.8 million premium assistance recipients. That existing budget is around Rp47 trillion, he said.

The extra funds are due to be disbursed in October and November to support BPJS Kesehatan’s finances. The announcement therefore describes two funding streams: assistance for premium recipients and additional support for the programme’s financial needs.

The government reported around Rp47 trillion for premium assistance recipients, plus an additional Rp20 trillion for BPJS Kesehatan’s finances in 2026.

The figures were presented by Nazara at the meeting’s press briefing. The announcement does not specify how the additional allocation will be divided among services, providers or other programme costs.

Sustainability and service quality

Sadikin said BPJS officials had sought clarity on the programme’s financial sustainability. He reported that the finance minister had assured them funding would be maintained as long as BPJS continued to deliver quality services and meet public needs.

That formulation links continued financial support to the programme’s performance, while the president’s instruction gives service quality a clear political emphasis. The account does not provide further detail on the criteria the government will use to assess quality or public need.

BPJS Kesehatan President Director Prihati Pujowaskito welcomed the additional funding and said the agency was improving its services. He also said it was taking measures to eliminate fraudulent practices and was committed to better meeting participants’ needs.

These are commitments and statements from officials, rather than evidence in the report of outcomes already achieved. The practical test will be whether participants experience shorter waits and better care, while the programme maintains the financial support described by the government.

What this means for investors

For investors assessing Indonesia’s policy environment, the announcement signals a government focus on the reliability and perceived fairness of a major public service. It also shows the administration pairing service directives with additional budget support for national health insurance.

The announcement alone does not establish how quickly hospital practice will change, how the funds will affect providers, or whether the programme’s finances will remain sustainable over time. Those questions depend on implementation and on the quality of services delivered to participants, subjects for which the report gives no further detail.

Investors should read the funding figures as the government’s stated allocations, not as a measure of the programme’s eventual performance. The emphasis on reducing waiting times, improving care and addressing fraud will matter most if it translates into tangible improvements for patients.

The next phase will turn on whether the government’s service ambitions and funding commitments produce a more consistent experience for BPJS participants across hospitals.

Stay informed: subscribe to our free Lombok Briefing, published twice a month (the 1st and 15th), for analysis like this.